Improving lives through transformative precision medicines
IDEAYA Biosciences is a clinical-stage precision medicine oncology company focused on synthetic lethality targets and translational biomarkers. Listed on NASDAQ (IDYA).
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free AccountBiopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
